Follow

"And according to preliminary work by Mateo Aboy, the director of research in biomedical innovation, AI and law at the University of Cambridge, around 3,000 patents have been filed to date on AI methods related to drug development and delivery alone. Aboy says they’re distributed among universities, big pharma, big tech and startups."

nature.com/articles/s41587-023

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.